A Novel Oxidovanadium (IV)-Orotate Complex as an Alternative Antidiabetic Agent: Synthesis, Characterization, and Biological Assessments

Table 1

EPR spectral data of the oxidovanadium (IV)-orotate complex.

			()	()	ΔB (G)
1.6719	1.5186	1.5952	78	71	1000

and= hyperfine constants; ΔB= full width at half maximum